Metopimazine
Metopimazine RP-9965, EXP-999, NG-101 l-(3-[2-(methylsulfonyl)-10H-phenothiazin-10-yl]propyl)-4-piperidinecarboxamide CAS 14008-44-7 MF C22 H27 N3 O3 S2 MW 445.60 4-Piperidinecarboxamide,...
View ArticleUSA Viewership touched 3 lakhs on New Drug Approvals
USA Viewership touched 3 lakhs on New Drug Approvals https://newdrugapprovals.org/ Total 16.9 lakhs in 213 countriesFiled under: BLOGS, Uncategorized Tagged: Anthony crasto, blogs, New drug approvals,...
View ArticleBMS 986205
BMS 986205 (2R)-N-(4-Chlorophenyl)-2-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]propanamide Cyclohexaneacetamide, N-(4-chlorophenyl)-4-(6-fluoro-4-quinolinyl)-α-methyl-, cis- Cyclohexaneacetamide,...
View ArticleFDA expands approved use of Kalydeco IVACAFTOR to treat additional mutations...
FDA expands approved use of Kalydeco to treat additional mutations of cystic fibrosis 05/17/2017 04:14 PM EDT The U.S. Food and Drug Administration today expanded the approved use of Kalydeco...
View ArticleFDA approves first drug Actemra (tocilizumab) to specifically treat giant...
FDA approves first drug to specifically treat giant cell arteritis 05/22/2017 The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat...
View ArticleFDA approves first cancer treatment for any solid tumor with a specific...
FDA approves first cancer treatment for any solid tumor with a specific genetic feature 05/23/2017 The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients...
View ArticleFDA approves first generic Strattera (atomoxetine) for the treatment of ADHD
FDA approves first generic Strattera (atomoxetine) for the treatment of ADHD 05/30/2017 04:49 PM EDT The U.S. Food and Drug Administration today approved the first generic versions of Strattera...
View ArticleTEGAFUR
Tegafur CAS 17902-23-7 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)- Molecular Weight,200.17, MF C8 H9 F N2 O3 172-173 °C Miyashita, Osamu; Chemical & Pharmaceutical...
View ArticleTILOGLIPTIN
PRESENTING 2 MOLECULES………..I AM NOT SURE WHICH IS TITLE MOLECULE EMAIL ME amcrasto@gmail.com Molecular Formula: C25H27N7O Molecular Weight: 441.539 g/mol...
View ArticleLanabecestat (formerly known as AZD3293 or LY3314814)
Lanabecestat Molecular FormulaC26H28N4O Average mass412.527 Da Dispiro[cyclohexane-1,2′-[2H]indene-1′(3′H),2”-[2H]imidazol]-4”-amine, 4-methoxy-5”-methyl-6′-[5-(1-propyn-1-yl)-3-pyridinyl]-,...
View ArticleHNIW, CL 20, 六硝基六氮杂异伍兹烷
HNIW, CL-20 Molecular FormulaC6H6N12O12 Average mass438.185 Da 1,3,4,7,8,10-hexanitrooctahydro-1H-5,2,6-(epiminomethanetriylimino)imidazo[4,5-b]pyrazine CAS 135285-90-4 Hexanitrohexaazaisowurtzitane...
View ArticleFDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic...
FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease 06/22/2017 The U.S. Food and Drug Administration today approved Haegarda, the first C1 Esterase Inhibitor (Human)...
View ArticleLisdexamphetamine
Lisdexamfetamine Molecular FormulaC15H25N3O Average mass263.379 Da 608137-32-2 [RN] Elvanse [Trade name] Hexanamide, 2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-, (2S)- Lisdexamfetamine...
View ArticleImigliptin dihydrochloride, Xuanzhu Pharma Co Ltd, NEW PATENT, WO 2017107945
Imigliptin dihydrochloride, Xuanzhu Pharma Co Ltd, NEW PATENT, WO 2017107945 https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017107945&redirectedID=true Applicants: XUANZHU PHARMA...
View ArticleNEW PATENT, PONESIMOD, CRYSTAL PHARMATECH, WO 2017107972
NEW PATENT, PONESIMOD, CRYSTAL PHARMATECH, WO 2017107972 Novel crystalline forms I, II and III of ponesimod . Useful as a selective sphingosine-1-phosphate receptor-1 (S1P1) receptor agonist, for the...
View ArticleCp2TiCl: An Ideal Reagent for Green Chemistry?
Green Chemistry International The development of Green Chemistry inevitably involves the development of green reagents. In this review, we highlight that Cp2TiCl is a reagent widely used in radical...
View ArticleIncreasing global access to the high-volume HIV drug nevirapine through...
Increasing global access to the high-volume HIV drug nevirapine through process intensification Green Chem., 2017, 19,2986-2991 DOI: 10.1039/C7GC00937B, Paper Jenson Verghese, Caleb J. Kong, Daniel...
View ArticleFDA approves new treatment Endari (L-glutamine oral powder) for sickle cell...
FDA approves new treatment for sickle cell disease 07/07/2017 The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle...
View ArticleLOXO 195
LOXO-195 CAS: 2097002-61-2 Chemical Formula: C20H21FN6O Molecular Weight: 380.4274 2097002-59-8 (RS-isomer) 1350884-56-8 (R racemic) Synonym: LOXO-195; LOXO 195; LOXO195. IUPAC:...
View ArticleFDA approves Vosevi for Hepatitis C
FDA approves Vosevi for Hepatitis C 07/18/2017 The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver...
View Article